((2,4-difluorocyclohexyl)((2-(hydroxy(methyl)amino)-2-oxoethyl)sulfonyl)methyl)phosphonic acid |
|
((2,4-difluorocyclohexyl)((2-(hydroxy(methyl)amino)-2-oxoethyl)thio)methyl)phosphonic acid |
|
((3,4-dichlorophenyl)((2-(hydroxy(methyl)amino)-2-oxoethyl)thio)methyl)phosphonic acid |
|
((3,4-dichlorophenyl)((2-(methyl(l1-oxidaneyl)amino)-2-oxoethyl)thio)methyl)phosphonic acid |
|
(3-(N-([1,1'-biphenyl]-4-yloxy)acetamido)propyl)phosphonic acid |
|
[({[(2,2-dimethylpropanoyl)oxy]methoxy}[(1E)-3-(N-hydroxyformamido)prop-1-en-1- yl]phosphoryl)oxy]methyl 2,2-dimethylpropanoate ( |
|
[(2,2-dimethyl-1-methylene-propoxy)methoxy-(1-hydroxy-2-oxo-4-piperidyl)phosphoryl]oxymethyl 2,2-dimethylpropanoate;oxido ammonium |
|
[(3,4-difluorophenyl)-[2-[hydroxy(methyl)amino]-2-oxo-ethoxy]methyl]phosphonic acid
|
|
[1-(3,4-difluorophenyl)-4-(hydroxyamino)-4-oxo-butyl]phosphonic acid
|
|
[1-(3,4-difluorophenyl)-4-[hydroxy(methyl)amino]-4-oxo-butyl]phosphonic acid
|
|
[2-(cyclohexa-2,4-dien-1-ylmethyl)-4-[hydroxy(methyl)amino]-4-oxo-butyl]phosphonic acid |
|
[2-cyclohexa-2,4-dien-1-yl-4-[hydroxy(methyl)amino]-4-oxo-butyl]phosphonic acid |
|
[4-(hydroxyamino)-4-oxo-1-phenyl-butyl]phosphonic acid
|
|
[4-[hydroxy(methyl)amino]-4-oxo-1-phenyl-butyl]phosphonic acid
|
|
[5-cyclohexa-2,4-dien-1-yl-2-[2-[hydroxy(methyl)amino]-2-oxo-ethyl]pentyl]phosphonic acid |
|
{3-[Acetyl(hydroxy)amino]propyl}phosphonic acid
|
|
1-(2-ethylsulfonylethyl)-2-methyl-5-nitro-imidazole (1EMI)
|
|
2,2-Dimethyl-propionic acid (2,2-dimethyl-propionyloxymethoxy)-[3-(formyl-hydroxy-amino)-1-methylpropyl]-phosphinoyloxymethyl ester |
|
2,2-Dimethyl-propionic acid [3-(acetyl-hydroxyamino)-1-methyl-propyl]-(2,2-dimethyl-propionyloxymethoxy)-phosphinoyloxymethyl ester |
|
2,4-bis(3-bromophenyl)-2-methyl-2,3-dihydro-1H-benzo[b][1,4] diazepine |
|
2-[acetoxymethoxy-[(E)-3-[acetyl(hydroxy)amino]prop-1-enyl]phosphoryl]oxyethyl acetate |
|
2-octadecynoic acid
|
|
3,3-dimethyl-11-phenyl2,3,4,5,10,11-hexahydro1Hdibenzo[b,e][1,4]diazepin1-one |
|
3-[acetyl(hydroxy)amino]propylphosphonic acid
|
|
3-[formyl(hydroxy)amino]propylphosphonic acid
|
|
3'-amido-3'-deoxy-n(6)-(1-naphthylmethyl)adenosines |
|
3-d model, suggested target |
|
4-(hydroxyamino)-4-oxobutylphosphonic acid
|
|
4-[hydroxy(methyl)amino]-4-oxobutyl phosphonic acid
|
|
7- (4-chlorophenyl)-1-[3,4-dihydroxy-5-(hydroxymethyl) tetrahydro-2-furanyl]-2,4 (1H,3H)-pteridinedione
|
|
Amodiaquine
|
|
Aplysinone d
|
|
Araplysillin i
|
|
Araplysillin n20-formamide |
|
Artesunate
|
|
Atovaquone
|
|
Benzimidazol-(2-yl)pentan-1-amine |
|
Bis(pivaloyloxymethyl) ester
|
|
Cassiarin-D
|
|
Chembridge 19754435
|
|
Chembridge 54282478
|
|
Flavonoids
|
|
fosfoxacin
|
|
fosmidomycin
|
|
Fosmidomycin cyclopropyl analogues |
|
Fr-33289
|
|
FR900098
|
|
Fr-900098
|
|
Furosemide
|
|
Galloyl triterpene |
|
Heme
|
|
Hmbpp
|
|
Homoaerothionin,
|
|
Hydroxamic acid
|
|
hydroxy-[hydroxy-[2-[2-[hydroxy(methyl)amino]-2-oxo-ethyl]-5-(m-tolyl)pentyl]phosphoryl]sodium(1+) |
|
Hydroxyfosmidomycin |
|
Imidazolopiperazine
|
|
Immucillin
|
|
Ligand-binding sites suggested target |
|
Mefloquine
|
|
methyl (1-(3,4-difluorocyclohexyl)-4-(hydroxyamino)-4-oxobutyl)phosphonate |
|
Mmv008138
|
|
Morpholino oligomer |
|
Mutations decrease pfdxr affinity, suggested target |
|
Oleanolic acid 28-O-beta-D-glucopyranoside
|
|
PfDXR-PPMO |
|
Sodium Hydrogen 2-((N-Hydroxy-N-methylcarbamoyl)methyl)-5-phenylpentylphosphonate |
|
Sodium Hydrogen 2-((N-Hydroxy-N-methylcarbamoyl)methyl)-6-phenylhexylphosphonate |
|
Suggested target
|
|
Thiosemicarbazone
|
|
Triclosan
|
|
X-ray crystal, suggested target |
|